These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31405804)

  • 1. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health.
    Lopez MI; Cocohoba J; Cohen SE; Trainor N; Levy MM; Dong BJ
    J Am Pharm Assoc (2003); 2020; 60(1):138-144. PubMed ID: 31405804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies.
    Bellman R; Mohebbi S; Nobahar N; Parizher J; Apollonio DE
    J Am Pharm Assoc (2003); 2022; 62(1):370-377.e3. PubMed ID: 34429253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!
    Lopez MI; Grant RM; Dong BJ
    J Am Pharm Assoc (2003); 2020; 60(4):e18-e24. PubMed ID: 32165026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes about community pharmacy access to HIV prevention medications in California.
    Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
    J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.
    Crawford ND; Josma D; Morris J; Hopkins R; Young HN
    J Am Pharm Assoc (2003); 2020; 60(4):602-608. PubMed ID: 32007364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing a collaborative practice agreement for HIV pre-exposure prophylaxis in the primary care setting.
    Lee LC; Pollak BA; Coffey CP
    J Am Pharm Assoc (2003); 2023; 63(1):383-388. PubMed ID: 36244883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of PrEP and PEP furnishing in San Francisco Bay Area pharmacies: An observational cross-sectional study.
    Herron G; Leong A; Patel K; Rasekhi K; Apollonio DE
    J Am Pharm Assoc (2003); 2024; 64(6):102201. PubMed ID: 39097189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States.
    Clement ME; Johnston BE; Eagle C; Taylor D; Rosengren AL; Goldstein BA; Seña AC
    AIDS Patient Care STDS; 2019 Aug; 33(8):366-371. PubMed ID: 31233329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and uptake of pre-exposure prophylaxis for HIV among low-income, HIV-negative heterosexuals in San Francisco.
    Namara D; Xie H; Miller D; Veloso D; McFarland W
    Int J STD AIDS; 2021 Jul; 32(8):704-709. PubMed ID: 33530898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to Discuss and Screen for Pre-Exposure Prophylaxis in Pharmacies Among Men Who Have Sex With Men.
    Crawford ND; Albarran T; Chamberlain A; Hopkins R; Josma D; Morris J; Onwubiko UN
    J Pharm Pract; 2021 Oct; 34(5):734-740. PubMed ID: 32067554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure and postexposure prophylaxis access in rural versus urban pharmacies in Georgia and Pennsylvania.
    Kislovskiy Y; Pino N; Crawford ND; Woitas T; Cason S; Konka A; Kimble T; Olson I; Villarreal D; Jarlenski M
    J Am Pharm Assoc (2003); 2024; 64(4):102084. PubMed ID: 38574992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community Levels of PrEP Use Among Men Who Have Sex with Men by Race/Ethnicity, San Francisco, 2017.
    Raymond HF; Snowden JM; Guigayoma J; McFarland W; Chen YH
    AIDS Behav; 2019 Oct; 23(10):2687-2693. PubMed ID: 30758787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing disparities in Pre-exposure Prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida.
    Butts SA; Young B; Blackmon J; Doblecki-Lewis S
    BMC Health Serv Res; 2023 Nov; 23(1):1311. PubMed ID: 38012701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute HIV at the Time of Initiation of Pre-exposure or Post-exposure Prophylaxis: Impact on Drug Resistance and Clinical Outcomes.
    Johnson KA; Chen MJ; Kohn R; Sachdev D; Bacon O; Lee S; Cohen SE
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):818-825. PubMed ID: 33512849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
    Tung EL; Thomas A; Eichner A; Shalit P
    Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities.
    Snowden JM; Chen YH; McFarland W; Raymond HF
    Sex Transm Infect; 2017 Feb; 93(1):52-55. PubMed ID: 27356041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic.
    Johnson KA; Hessol NA; Kohn R; Nguyen TQ; Mara ES; Hsu L; Scheer S; Cohen SE
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):159-165. PubMed ID: 31192823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California.
    Hunter LA; Packel LJ; Chitle P; Beltran RM; Rafie S; De Martini L; Dong B; Harris O; Holloway IW; Miyashita Ochoa A; McCoy SI
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad549. PubMed ID: 38023549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
    Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
    Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation.
    Khosropour CM; Backus KV; Means AR; Beauchamps L; Johnson K; Golden MR; Mena L
    AIDS Patient Care STDS; 2020 Jan; 34(1):1-6. PubMed ID: 31944854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.